RMG Wealth Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.8K Hold
300
– – ﹤0.01% 218
2026
Q2
$27.9K Sell
300
-42
-12% -$3.52K ﹤0.01% 211
2026
Q1
$26.4K Buy
+342
New +$28.2K ﹤0.01% 211
2025
Q4
– Sell
-300
Closed -$23.4K – 429
2025
Q3
$23.4K Hold
300
– – ﹤0.01% 184
2025
Q2
$23.1K Buy
+300
New +$22.4K ﹤0.01% 184

Other funds holding EW

RMG Wealth Management's EW Position: Q3 2026 in Review

RMG Wealth Management held its Edwards Lifesciences (EW) position steady in Q3 2026 at 300 shares worth $26.8K. The position accounts for ﹤0.01% of the portfolio, ranked #218.

RMG Wealth Management first reported a position in EW in Q2 2025 and has held it in 5 quarters since. The position peaked at $27.9K in Q2 2026. 1,339 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • RMG Wealth Management held 300 shares of Edwards Lifesciences worth $26.8K as of Q3 2026.
  • RMG Wealth Management left its Edwards Lifesciences share count unchanged in Q3 2026.
  • Edwards Lifesciences made up ﹤0.01% of RMG Wealth Management's portfolio in Q3 2026, its #218 holding.
  • RMG Wealth Management first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 5 quarters since.
  • RMG Wealth Management's Edwards Lifesciences position peaked at $27.9K in Q2 2026.
  • 1,339 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on RMG Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.